Pulsenmore Ltd

Pulsenmore Ltd(PLSM)股票分析

$1.510

-0.039 (-2.57%)收盤時

Loading chart…
最高
1.610
開盤
1.610
成交量加權均價
1.51
成交量
6.64K
市值
—
最低
1.420
成交金額
10.04K
企業價值/稅息折舊攤銷前利潤(TTM)
0.00

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products.

AI 分析 of Pulsenmore Ltd (PLSM)

賣出

Pulsenmore Ltd is not a good buy right now. The current price is $1.51, which is significantly down 84.02% year-to-date. The RSI is at 25.769, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the stock has a 52-week high of $12.97, showing a large gap from the current price. The main risk is the negative sentiment reflected in the 5-day change of -9.57% and the ongoing volatility in the stock's performance.

估值指標

Pulsenmore Ltd(PLSM)目前預期本益比為 0.00,5 年平均預期本益比為 。

預期本益比

5 年均值 P/E
目前P/E
0.00

預期 EV/EBITDA

5 年均值 EV/EBITDA
目前EV/EBITDA
0.00

預期股價營收比

5 年均值 P/S
目前P/S
0.00

持有 PLSM 的大戶

A

Aquamarine Financial (Cayman) Ltd

+ 持有PLSM

+0.03%

3個月報酬率

事件時間軸

2026-10-13 (ET)

07:30:00

Pulsenmore Appoints David Woods as Chief Commercial Officer

2026-09-17 (ET)

07:30:00

Pulsenmore Completes Registration of Pulsenmore FC

2026-08-31 (ET)

16:30:00

Major Averages Decline as September Rate Hike Probability Rises to 60%

12:00:00

Major Averages Broadly Lower as Oil Prices Rise

07:30:00

Pulsenmore Reports 1H Revenue of $2.042M

資訊

PLSM 常見問題 —— 由 Alphio AI 解答

Pulsenmore Ltd is an Israel-based medical equipment company. The Company engaged in the field of research and development activity, production, marketing and sales worldwide of solutions and technologies that concern portable ultrasound devices for home use by the patient for a remote physical examination or monitoring using telehealth technology. he company has developed and sells two miniaturized ultrasound systems: the first is called PulseNmore ES, for performing home ultrasound tests for pregnant women; and the second is called PulseNmore FC, for performing a self-test of the size of the follicles in women who are in the process in vitro fertilization. Both systems make use of a smart mobile phone and make the test accessible without the need o visit in clinic or hospital, while being able to transfer film for the doctor, the treating medical team or the hotline online. Moreover the COmpany delivers software for its products. It operates in the Healthcare sector.

Pulsenmore Ltd is not a good buy right now. The current price is $1.51, which is significantly down 84.02% year-to-date. The RSI is at 25.769, indicating that the stock is oversold, but this could also suggest continued weakness. The forward P/E ratio is 0, reflecting uncertainty in future earnings, and the stock has a 52-week high of $12.97, showing a large gap from the current price. The main risk is the negative sentiment reflected in the 5-day change of -9.57% and the ongoing volatility in the stock's performance.

暫無貼文

註冊或登入後參與討論

相關文章

本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。

開始交易